PCI Synthesis, Inc. , a drug substance manufacturer of new chemical entities and generic active pharmaceutical ingredients, has formed its cGMP Advanced Polymer Development and Manufacturing Group, which is currently developing and manufacturing more than a dozen advanced polymer-based projects.

The team currently includes several PhD.-level polymer chemists with broad expertise in the development, scale-up, and eventual cGMP manufacturing of these materials. The team is also supported by PCI Synthesis's existing Kilo Lab team. Products in development include a broad range of polymer-based materials, including: implantable medical devices including biodegradable implants; nano-polymer particle technology. combination API and polymer technologiesl drug delivery technologies; therapeutics and excipients; and medical-grade coatings. The PCI Synthesis Advanced Polymer Manufacturing Group operates out of the company's development lab in Devens, Massachusetts and collaborates with the comany’s GMP facilities in Newburyport, Massachusetts.

Source: PCI Synthesis